The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT05095857
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Registry
-
NCT05095857 -
2021-003716-12
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT05095857. Randomized; quadruple masking; primary purpose treatment. Start 2023-09-15 (actual); primary completion 2028-09-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
- Acronym
- KETA-BID
- Condition
- Subarachnoid Hemorrhage, Aneurysmal
- Condition
- Intracerebral Hemorrhage
- Condition
- Traumatic Brain Injury
- Intervention (Drug)
- S-ketamine
- Intervention (Other)
- Isotonic saline (placebo)
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Collaborator
- Copenhagen Trial Unit, Center for Clinical Intervention Research
Record details
- Record id
cardio:ct-nct05095857- Content hash
b75c746b027ae42126f7a2d0ee15b396db2ab753871d74b7b2c6ae311ef3bb4c